Vivo Capital VIII, LLC

Average Profitability
7.82%
Insider Buys Quantity
4
Insider Buys Sum
$39.48M
Insider Sells Quantity
13
Insider Sells Sum
$29.94M

Insider Activity of Vivo Capital VIII, LLC

The largest purchase of all time was on 2018-07-20 and amounted to 706360 shares of Crinetics Pharmaceuticals, Inc. for $13.15M.

The largest sale of all time was on 2019-03-20 and amounted to 834000 shares of Crinetics Pharmaceuticals, Inc. for $18.56M.

Biography of Vivo Capital VIII, LLC

No biography is available at this moment.

2021-02-09PurchaseTerns Pharmaceuticals, Inc.
TERN
10 percent owner
475,000
2.5596%
$17.00$8.07M-48.44%
2020-10-20PurchaseAligos Therapeutics, Inc.
ALGS
10 percent owner
550,000
1.9863%
$15.00$8.25M+61.44%
2020-04-17SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
84,598
0.2702%
$15.40$1.3M+0.52%
2020-04-16SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
30,190
0.0944%
$15.20$458,888-0.42%
2020-04-15SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
215,810
0.688%
$15.50$3.35M-0.42%
2020-04-07SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
6,115
0.0212%
$14.20$86,833+17.71%
2020-04-03SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
300,000
0.9993%
$13.80$4.14M+16.11%
2020-03-09SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
528
0.0022%
$19.50$10,296-20.15%
2020-02-10SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
7,555
0.0308%
$21.40$161,677-29.01%
2020-02-07SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
5,905
0.0245%
$22.00$129,910-29.7%
2020-02-04SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
24,336
0.1018%
$22.80$554,861-31.63%
2020-01-31SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
10,800
0.0446%
$21.70$234,360-29.05%
2020-01-30SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
15,200
0.062%
$22.10$335,920-31.04%
2020-01-29SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
27,840
0.114%
$22.20$618,048-31.03%
2019-03-20SaleCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
834,000
3.072%
$22.25$18.56M-12.64%
2018-07-20PurchaseCrinetics Pharmaceuticals, Inc.
CRNX
10 percent owner
706,360
2.8566%
$18.62$13.15M+10.46%
2018-01-25PurchaseVYNE Therapeutics Inc.
VYNE
10 percent owner
588,236
1.9809%
$17.00$10M-71.72%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.